Skip to main content
. 2016 Dec 27;55(1):729–739. doi: 10.1080/13880209.2016.1270972

Figure 4.

Figure 4.

Suppressive effects of silibinin on key oncogenic pathways in MDA-MB-435/WT and MDA-MB-435/DOX cell lines. Western blotting was used to measure the level of oncogenic proteins in the cells treated with an increasing concentration of silibinin. These results are representative of three independent experiments.